Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03884400|
Recruitment Status : Not yet recruiting
First Posted : March 21, 2019
Last Update Posted : August 7, 2019
|Condition or disease||Intervention/treatment|
|Cancer Pregnancy Related Gastro-Intestinal Disorder Cardio-Respiratory Distress Women's Health: Endometriosis Autoimmune Diseases Nephritis Healthy Neuro-Degenerative Disease||Procedure: Specimens obtained from surgical, phlebotomy or other non-invasive procedure|
iSpecimen has built a partner network comprised of supplying institutions that have ethically acquired human biospecimens and created biorepositories/biobanks to store the specimens and data.
Many of these biorepositories have protocols allowing for the collection of their samples but require an additional IRB or ethics review for the distribution of their samples.
This protocol establishes a method of such supply sites to allow their specimens to be distributed and used for research via iSpecimen's technology and network of research clients.
|Study Type :||Observational|
|Estimated Enrollment :||1000000 participants|
|Official Title:||iSpecimen Network Distribution of Biospecimens From Biorepositories/Biobanks for Research Use|
|Estimated Study Start Date :||December 1, 2019|
|Estimated Primary Completion Date :||December 31, 2029|
|Estimated Study Completion Date :||March 1, 2030|
Subjects who have provided consent for specimen collection
Re-consent will not be required. This protocol allows distribution of the specimens following the terms agreed to by the subject in the original consent.
Procedure: Specimens obtained from surgical, phlebotomy or other non-invasive procedure
- Distribution of Biospecimens From Biorepositories/Biobanks for Research Use [ Time Frame: 15 years ]The number of specimens and subjects distributed per disease will be measured and reported.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03884400
|Contact: Emily Hubbardemail@example.com|
|Contact: Jill Mullanfirstname.lastname@example.org|
|United States, Massachusetts|
|iSpecimen||Not yet recruiting|
|Lexington, Massachusetts, United States, 02420|
|Contact: Emily Hubbard 256-797-0003 email@example.com|
|Principal Investigator:||Chris Ianelli, MD, PhD||iSpecimen Inc|